5-methylurapidil has been researched along with ah 11110a in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goetz, AS; King, HK; Lutz, MW; Queen, KL; Rimele, TJ; Saussy, DL | 1 |
| Farias-Rodríguez, VM; Gallardo-Ortíz, IA; Gómez-Zamudio, JH; Lázaro-Suárez, ML; Tanoue, A; Tsujimoto, G; Villalobos-Molina, R | 1 |
| Asbun-Bojalil, J; Castillo-Henkel, C; Castillo-Hernández, MC; Cervantes-Cruz, J; Cruz-Domínguez, MP; Miliar-García, A; Montes-Cortés, DH; Reséndiz-Ramírez, AC; Villalobos-Molina, R | 1 |
3 other study(ies) available for 5-methylurapidil and ah 11110a
| Article | Year |
|---|---|
Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype.
Topics: Animals; Aorta; Buspirone; Cattle; Cricetinae; Fibroblasts; Humans; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship | 1996 |
Chloroethylclonidine reveals that alpha (1 A)-adrenoceptors mediate contraction in aorta of alpha (1 D)-adrenoceptor knockout mice.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta; Clonidine; Dose-Response Relationship, Drug; Imines; In Vitro Techniques; Mice; Mice, Knockout; Norepinephrine; Piperazines; Piperidines; Receptors, Adrenergic, alpha-1; Vasoconstriction; Vasoconstrictor Agents | 2005 |
Evidence of alpha1-adrenoceptor functional changes in omental arteries of patients with end-stage renal disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Arteries; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Imines; Kidney Failure, Chronic; Male; Middle Aged; Omentum; Phenylephrine; Piperazines; Piperidines; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstriction; Vasoconstrictor Agents | 2008 |